REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 39 filers reported holding REPARE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,408 | -54.4% | 1,855 | -60.1% | 0.00% | – |
| Q2 2023 | $49,134 | +129.3% | 4,644 | +113.2% | 0.00% | – |
| Q1 2023 | $21,432 | -71.1% | 2,178 | -56.8% | 0.00% | – |
| Q4 2022 | $74,167 | +72.5% | 5,042 | +42.0% | 0.00% | – |
| Q3 2022 | $43,000 | +10.3% | 3,551 | +26.3% | 0.00% | – |
| Q2 2022 | $39,000 | -18.8% | 2,812 | -15.9% | 0.00% | – |
| Q1 2022 | $48,000 | -60.3% | 3,344 | -41.8% | 0.00% | – |
| Q4 2021 | $121,000 | +26.0% | 5,744 | +57.3% | 0.00% | – |
| Q3 2021 | $96,000 | -46.4% | 3,652 | -36.4% | 0.00% | – |
| Q2 2021 | $179,000 | +316.3% | 5,746 | +306.4% | 0.00% | – |
| Q1 2021 | $43,000 | +514.3% | 1,414 | +607.0% | 0.00% | – |
| Q4 2020 | $7,000 | -65.0% | 200 | -69.9% | 0.00% | – |
| Q3 2020 | $20,000 | – | 664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |